Literature DB >> 33552642

Unusual Characteristics and Variable Expressivity in a Brazilian Family with Cherubism.

Desirée Deconte1, Elisa Pacheco Estima Correia2, Géssica Haubert2, Vinicius de Souza2, Jamile Dutra Correia1, Marcia Angelica Peter Maahs3, Paulo Ricardo Gazzola Zen1,4, Marilu Fiegenbaum1,5, Rafael Fabiano Machado Rosa1,4.   

Abstract

Cherubism is a rare genetic condition characterized by a bone nonneoplastic disease. We aimed to report a 6-year-old girl with cherubism presenting similar cases in the maternal family. However, her mother and grandmother seemed to be asymptomatic. The patient had an enlarged and asymmetric jaw with multiple enlarged cervical lymph nodes that increased in size with time. Sanger sequencing revealed a heterozygous mutation in exon 9 of SH3BP2 not only in the patient but also in her mother. Thus, we observed a variable expression and a probably reduced penetrance within the family, as well as unusual characteristics of the patient (in this case, the asymmetrical involvement of the jaw). Thieme. All rights reserved.

Entities:  

Keywords:  asymmetry; cherubism; variable expressivity

Year:  2020        PMID: 33552642      PMCID: PMC7853913          DOI: 10.1055/s-0040-1705095

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  43 in total

Review 1.  Cherubism in siblings: a case report.

Authors:  Ravikiran Ongole; Rejeev S Pillai; Keerthilatha M Pai
Journal:  J Can Dent Assoc       Date:  2003-03       Impact factor: 1.316

2.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

Authors:  D K Lahiri; J I Nurnberger
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

3.  Cherubism: clinicoradiographic features, treatment, and long-term follow-up of 8 cases.

Authors:  Edgard Carvalho Silva; Guilherme Costa Carvalho Silva; Tainah Couto Vieira
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

Review 4.  Diagnosis and treatment of familial cherubism characterized by early onset and rapid development.

Authors:  Carmen Mortellaro; Lucilla Bello; Alberta Greco Lucchina; Angela Pucci
Journal:  J Craniofac Surg       Date:  2009-01       Impact factor: 1.046

5.  Cherubism with multiple dental abnormalities: a rare presentation.

Authors:  Satya Ranjan Misra; Lora Mishra; Neeta Mohanty; Susant Mohanty
Journal:  BMJ Case Rep       Date:  2014-10-09

6.  Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.

Authors:  Yasuyoshi Ueki; Chin-Yu Lin; Makoto Senoo; Takeshi Ebihara; Naoki Agata; Masahiro Onji; Yasunori Saheki; Toshihisa Kawai; Padma M Mukherjee; Ernst Reichenberger; Bjorn R Olsen
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

7.  Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.

Authors:  Steven A Lietman; Natasha Kalinchinko; Xichao Deng; Ronald Kohanski; Michael A Levine
Journal:  Hum Mutat       Date:  2006-07       Impact factor: 4.878

8.  Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.

Authors:  Prokopios P Argyris; Rajaram Gopalakrishnan; Ying Hu; Ernst J Reichenberger; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2017-07-18

Review 9.  Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature.

Authors:  Yasar Ozkan; A Varol; N Turker; N Aksakalli; S Basa
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-09       Impact factor: 1.675

10.  A possible case of cherubism in a 17th-century Korean mummy.

Authors:  Israel Hershkovitz; Mark Spigelman; Rachel Sarig; Do-Sun Lim; In Sun Lee; Chang Seok Oh; Hila May; Elisabetta Boaretto; Yi-Suk Kim; Soong Deok Lee; Nathan Peled; Myeung Ju Kim; Talya Toledano; Gila Kahila Bar-Gal; Dong Hoon Shin
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.